Physicians reaction to FDA decision to rescind breast cancer indication from Avastin

[News]

Sermo, the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.

More... (http://www.news-medical.net/news/20110205/Physicians-reaction-to-FDA-decision-to-rescind-breast-cancer-indication-from-Avastin.aspx)